Stock Analysis on Net

DexCom Inc. (NASDAQ:DXCM)

This company has been moved to the archive! The financial data has not been updated since October 26, 2023.

Analysis of Solvency Ratios

Microsoft Excel

Solvency Ratios (Summary)

DexCom Inc., solvency ratios

Microsoft Excel
Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018
Debt Ratios
Debt to equity 0.95 0.78 0.95 1.22 1.53
Debt to equity (including operating lease liability) 1.01 0.84 1.01 1.32 1.53
Debt to capital 0.49 0.44 0.49 0.55 0.61
Debt to capital (including operating lease liability) 0.50 0.46 0.50 0.57 0.61
Debt to assets 0.38 0.36 0.40 0.45 0.53
Debt to assets (including operating lease liability) 0.40 0.39 0.43 0.48 0.53
Financial leverage 2.53 2.16 2.35 2.71 2.89
Coverage Ratios
Interest coverage 22.01 2.73 3.66 2.73 -4.57
Fixed charge coverage 10.49 2.41 3.18 2.44 -2.59

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).

Solvency ratio Description The company
Debt to equity ratio A solvency ratio calculated as total debt divided by total shareholders’ equity. DexCom Inc. debt to equity ratio improved from 2020 to 2021 but then deteriorated significantly from 2021 to 2022.
Debt to equity ratio (including operating lease liability) A solvency ratio calculated as total debt (including operating lease liability) divided by total shareholders’ equity. DexCom Inc. debt to equity ratio (including operating lease liability) improved from 2020 to 2021 but then slightly deteriorated from 2021 to 2022 not reaching 2020 level.
Debt to capital ratio A solvency ratio calculated as total debt divided by total debt plus shareholders’ equity. DexCom Inc. debt to capital ratio improved from 2020 to 2021 but then deteriorated significantly from 2021 to 2022.
Debt to capital ratio (including operating lease liability) A solvency ratio calculated as total debt (including operating lease liability) divided by total debt (including operating lease liability) plus shareholders’ equity. DexCom Inc. debt to capital ratio (including operating lease liability) improved from 2020 to 2021 but then slightly deteriorated from 2021 to 2022 not reaching 2020 level.
Debt to assets ratio A solvency ratio calculated as total debt divided by total assets. DexCom Inc. debt to assets ratio improved from 2020 to 2021 but then slightly deteriorated from 2021 to 2022.
Debt to assets ratio (including operating lease liability) A solvency ratio calculated as total debt (including operating lease liability) divided by total assets. DexCom Inc. debt to assets ratio (including operating lease liability) improved from 2020 to 2021 but then slightly deteriorated from 2021 to 2022.
Financial leverage ratio A solvency ratio calculated as total assets divided by total shareholders’ equity. DexCom Inc. financial leverage ratio decreased from 2020 to 2021 but then increased from 2021 to 2022 exceeding 2020 level.

Solvency ratio Description The company
Interest coverage ratio A solvency ratio calculated as EBIT divided by interest payments. DexCom Inc. interest coverage ratio deteriorated from 2020 to 2021 but then improved from 2021 to 2022 exceeding 2020 level.
Fixed charge coverage ratio A solvency ratio calculated as earnings before fixed charges and tax divided by fixed charges. DexCom Inc. fixed charge coverage ratio deteriorated from 2020 to 2021 but then improved from 2021 to 2022 exceeding 2020 level.

Debt to Equity

DexCom Inc., debt to equity calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018
Selected Financial Data (US$ in thousands)
Short-term finance lease liabilities 4,200 3,300 8,800 600
Current portion of long-term senior convertible notes 772,600
Long-term senior convertible notes 1,197,700 1,702,700 1,667,200 1,059,700 1,010,300
Long-term finance lease liabilities 59,600 57,000 54,000 14,400 7,300
Total debt 2,034,100 1,763,000 1,730,000 1,074,700 1,017,600
 
Stockholders’ equity 2,131,800 2,251,500 1,826,500 882,600 663,300
Solvency Ratio
Debt to equity1 0.95 0.78 0.95 1.22 1.53
Benchmarks
Debt to Equity, Competitors2
Abbott Laboratories 0.46 0.50 0.57 0.58
Cigna Group 0.69 0.71 0.65 0.83
CVS Health Corp. 0.74 0.75 0.93 1.07
Elevance Health Inc. 0.66 0.64 0.60 0.63
Humana Inc. 0.75 0.80 0.51 0.49
Intuitive Surgical Inc. 0.00 0.00 0.00 0.00
Medtronic PLC 0.46 0.51 0.49 0.51
UnitedHealth Group Inc. 0.74 0.64 0.66 0.71
Debt to Equity, Sector
Health Care Equipment & Services 0.63 0.63 0.65 0.72
Debt to Equity, Industry
Health Care 0.72 0.78 0.90 0.91

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).

1 2022 Calculation
Debt to equity = Total debt ÷ Stockholders’ equity
= 2,034,100 ÷ 2,131,800 = 0.95

2 Click competitor name to see calculations.

Solvency ratio Description The company
Debt to equity ratio A solvency ratio calculated as total debt divided by total shareholders’ equity. DexCom Inc. debt to equity ratio improved from 2020 to 2021 but then deteriorated significantly from 2021 to 2022.

Debt to Equity (including Operating Lease Liability)

DexCom Inc., debt to equity (including operating lease liability) calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018
Selected Financial Data (US$ in thousands)
Short-term finance lease liabilities 4,200 3,300 8,800 600
Current portion of long-term senior convertible notes 772,600
Long-term senior convertible notes 1,197,700 1,702,700 1,667,200 1,059,700 1,010,300
Long-term finance lease liabilities 59,600 57,000 54,000 14,400 7,300
Total debt 2,034,100 1,763,000 1,730,000 1,074,700 1,017,600
Short-term operating lease liabilities 20,500 20,500 16,500 13,600
Long-term operating lease liabilities 94,600 98,600 101,800 72,400
Total debt (including operating lease liability) 2,149,200 1,882,100 1,848,300 1,160,700 1,017,600
 
Stockholders’ equity 2,131,800 2,251,500 1,826,500 882,600 663,300
Solvency Ratio
Debt to equity (including operating lease liability)1 1.01 0.84 1.01 1.32 1.53
Benchmarks
Debt to Equity (including Operating Lease Liability), Competitors2
Abbott Laboratories 0.49 0.54 0.61 0.61
Cigna Group 0.70 0.73 0.67 0.84
CVS Health Corp. 1.00 1.01 1.23 1.39
Elevance Health Inc. 0.69 0.67 0.63 0.65
Humana Inc. 0.79 0.84 0.54 0.53
Intuitive Surgical Inc. 0.01 0.01 0.01 0.01
Medtronic PLC 0.48 0.53 0.51 0.51
UnitedHealth Group Inc. 0.80 0.70 0.73 0.77
Debt to Equity (including Operating Lease Liability), Sector
Health Care Equipment & Services 0.71 0.71 0.74 0.81
Debt to Equity (including Operating Lease Liability), Industry
Health Care 0.77 0.84 0.96 0.97

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).

1 2022 Calculation
Debt to equity (including operating lease liability) = Total debt (including operating lease liability) ÷ Stockholders’ equity
= 2,149,200 ÷ 2,131,800 = 1.01

2 Click competitor name to see calculations.

Solvency ratio Description The company
Debt to equity ratio (including operating lease liability) A solvency ratio calculated as total debt (including operating lease liability) divided by total shareholders’ equity. DexCom Inc. debt to equity ratio (including operating lease liability) improved from 2020 to 2021 but then slightly deteriorated from 2021 to 2022 not reaching 2020 level.

Debt to Capital

DexCom Inc., debt to capital calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018
Selected Financial Data (US$ in thousands)
Short-term finance lease liabilities 4,200 3,300 8,800 600
Current portion of long-term senior convertible notes 772,600
Long-term senior convertible notes 1,197,700 1,702,700 1,667,200 1,059,700 1,010,300
Long-term finance lease liabilities 59,600 57,000 54,000 14,400 7,300
Total debt 2,034,100 1,763,000 1,730,000 1,074,700 1,017,600
Stockholders’ equity 2,131,800 2,251,500 1,826,500 882,600 663,300
Total capital 4,165,900 4,014,500 3,556,500 1,957,300 1,680,900
Solvency Ratio
Debt to capital1 0.49 0.44 0.49 0.55 0.61
Benchmarks
Debt to Capital, Competitors2
Abbott Laboratories 0.31 0.34 0.36 0.37
Cigna Group 0.41 0.42 0.40 0.45
CVS Health Corp. 0.42 0.43 0.48 0.52
Elevance Health Inc. 0.40 0.39 0.38 0.39
Humana Inc. 0.43 0.44 0.34 0.33
Intuitive Surgical Inc. 0.00 0.00 0.00 0.00
Medtronic PLC 0.31 0.34 0.33 0.34
UnitedHealth Group Inc. 0.43 0.39 0.40 0.41
Debt to Capital, Sector
Health Care Equipment & Services 0.39 0.39 0.39 0.42
Debt to Capital, Industry
Health Care 0.42 0.44 0.47 0.48

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).

1 2022 Calculation
Debt to capital = Total debt ÷ Total capital
= 2,034,100 ÷ 4,165,900 = 0.49

2 Click competitor name to see calculations.

Solvency ratio Description The company
Debt to capital ratio A solvency ratio calculated as total debt divided by total debt plus shareholders’ equity. DexCom Inc. debt to capital ratio improved from 2020 to 2021 but then deteriorated significantly from 2021 to 2022.

Debt to Capital (including Operating Lease Liability)

DexCom Inc., debt to capital (including operating lease liability) calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018
Selected Financial Data (US$ in thousands)
Short-term finance lease liabilities 4,200 3,300 8,800 600
Current portion of long-term senior convertible notes 772,600
Long-term senior convertible notes 1,197,700 1,702,700 1,667,200 1,059,700 1,010,300
Long-term finance lease liabilities 59,600 57,000 54,000 14,400 7,300
Total debt 2,034,100 1,763,000 1,730,000 1,074,700 1,017,600
Short-term operating lease liabilities 20,500 20,500 16,500 13,600
Long-term operating lease liabilities 94,600 98,600 101,800 72,400
Total debt (including operating lease liability) 2,149,200 1,882,100 1,848,300 1,160,700 1,017,600
Stockholders’ equity 2,131,800 2,251,500 1,826,500 882,600 663,300
Total capital (including operating lease liability) 4,281,000 4,133,600 3,674,800 2,043,300 1,680,900
Solvency Ratio
Debt to capital (including operating lease liability)1 0.50 0.46 0.50 0.57 0.61
Benchmarks
Debt to Capital (including Operating Lease Liability), Competitors2
Abbott Laboratories 0.33 0.35 0.38 0.38
Cigna Group 0.41 0.42 0.40 0.46
CVS Health Corp. 0.50 0.50 0.55 0.58
Elevance Health Inc. 0.41 0.40 0.39 0.40
Humana Inc. 0.44 0.46 0.35 0.34
Intuitive Surgical Inc. 0.01 0.01 0.01 0.01
Medtronic PLC 0.32 0.35 0.34 0.34
UnitedHealth Group Inc. 0.45 0.41 0.42 0.44
Debt to Capital (including Operating Lease Liability), Sector
Health Care Equipment & Services 0.41 0.41 0.43 0.45
Debt to Capital (including Operating Lease Liability), Industry
Health Care 0.44 0.46 0.49 0.49

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).

1 2022 Calculation
Debt to capital (including operating lease liability) = Total debt (including operating lease liability) ÷ Total capital (including operating lease liability)
= 2,149,200 ÷ 4,281,000 = 0.50

2 Click competitor name to see calculations.

Solvency ratio Description The company
Debt to capital ratio (including operating lease liability) A solvency ratio calculated as total debt (including operating lease liability) divided by total debt (including operating lease liability) plus shareholders’ equity. DexCom Inc. debt to capital ratio (including operating lease liability) improved from 2020 to 2021 but then slightly deteriorated from 2021 to 2022 not reaching 2020 level.

Debt to Assets

DexCom Inc., debt to assets calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018
Selected Financial Data (US$ in thousands)
Short-term finance lease liabilities 4,200 3,300 8,800 600
Current portion of long-term senior convertible notes 772,600
Long-term senior convertible notes 1,197,700 1,702,700 1,667,200 1,059,700 1,010,300
Long-term finance lease liabilities 59,600 57,000 54,000 14,400 7,300
Total debt 2,034,100 1,763,000 1,730,000 1,074,700 1,017,600
 
Total assets 5,391,700 4,863,600 4,290,500 2,395,000 1,916,000
Solvency Ratio
Debt to assets1 0.38 0.36 0.40 0.45 0.53
Benchmarks
Debt to Assets, Competitors2
Abbott Laboratories 0.23 0.24 0.26 0.27
Cigna Group 0.22 0.22 0.21 0.24
CVS Health Corp. 0.23 0.24 0.28 0.31
Elevance Health Inc. 0.23 0.24 0.23 0.26
Humana Inc. 0.27 0.29 0.20 0.20
Intuitive Surgical Inc. 0.00 0.00 0.00 0.00
Medtronic PLC 0.27 0.28 0.27 0.28
UnitedHealth Group Inc. 0.23 0.22 0.22 0.23
Debt to Assets, Sector
Health Care Equipment & Services 0.23 0.23 0.24 0.26
Debt to Assets, Industry
Health Care 0.27 0.28 0.30 0.31

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).

1 2022 Calculation
Debt to assets = Total debt ÷ Total assets
= 2,034,100 ÷ 5,391,700 = 0.38

2 Click competitor name to see calculations.

Solvency ratio Description The company
Debt to assets ratio A solvency ratio calculated as total debt divided by total assets. DexCom Inc. debt to assets ratio improved from 2020 to 2021 but then slightly deteriorated from 2021 to 2022.

Debt to Assets (including Operating Lease Liability)

DexCom Inc., debt to assets (including operating lease liability) calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018
Selected Financial Data (US$ in thousands)
Short-term finance lease liabilities 4,200 3,300 8,800 600
Current portion of long-term senior convertible notes 772,600
Long-term senior convertible notes 1,197,700 1,702,700 1,667,200 1,059,700 1,010,300
Long-term finance lease liabilities 59,600 57,000 54,000 14,400 7,300
Total debt 2,034,100 1,763,000 1,730,000 1,074,700 1,017,600
Short-term operating lease liabilities 20,500 20,500 16,500 13,600
Long-term operating lease liabilities 94,600 98,600 101,800 72,400
Total debt (including operating lease liability) 2,149,200 1,882,100 1,848,300 1,160,700 1,017,600
 
Total assets 5,391,700 4,863,600 4,290,500 2,395,000 1,916,000
Solvency Ratio
Debt to assets (including operating lease liability)1 0.40 0.39 0.43 0.48 0.53
Benchmarks
Debt to Assets (including Operating Lease Liability), Competitors2
Abbott Laboratories 0.24 0.26 0.27 0.28
Cigna Group 0.22 0.22 0.22 0.24
CVS Health Corp. 0.31 0.33 0.37 0.40
Elevance Health Inc. 0.24 0.25 0.24 0.27
Humana Inc. 0.28 0.31 0.21 0.22
Intuitive Surgical Inc. 0.01 0.01 0.01 0.01
Medtronic PLC 0.27 0.29 0.28 0.28
UnitedHealth Group Inc. 0.25 0.24 0.24 0.26
Debt to Assets (including Operating Lease Liability), Sector
Health Care Equipment & Services 0.26 0.27 0.27 0.29
Debt to Assets (including Operating Lease Liability), Industry
Health Care 0.29 0.30 0.32 0.33

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).

1 2022 Calculation
Debt to assets (including operating lease liability) = Total debt (including operating lease liability) ÷ Total assets
= 2,149,200 ÷ 5,391,700 = 0.40

2 Click competitor name to see calculations.

Solvency ratio Description The company
Debt to assets ratio (including operating lease liability) A solvency ratio calculated as total debt (including operating lease liability) divided by total assets. DexCom Inc. debt to assets ratio (including operating lease liability) improved from 2020 to 2021 but then slightly deteriorated from 2021 to 2022.

Financial Leverage

DexCom Inc., financial leverage calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018
Selected Financial Data (US$ in thousands)
Total assets 5,391,700 4,863,600 4,290,500 2,395,000 1,916,000
Stockholders’ equity 2,131,800 2,251,500 1,826,500 882,600 663,300
Solvency Ratio
Financial leverage1 2.53 2.16 2.35 2.71 2.89
Benchmarks
Financial Leverage, Competitors2
Abbott Laboratories 2.03 2.10 2.21 2.18
Cigna Group 3.21 3.29 3.09 3.44
CVS Health Corp. 3.21 3.10 3.32 3.48
Elevance Health Inc. 2.83 2.70 2.61 2.44
Humana Inc. 2.81 2.76 2.55 2.42
Intuitive Surgical Inc. 1.17 1.14 1.15 1.18
Medtronic PLC 1.73 1.81 1.79 1.79
UnitedHealth Group Inc. 3.16 2.96 3.01 3.02
Financial Leverage, Sector
Health Care Equipment & Services 2.73 2.68 2.70 2.75
Financial Leverage, Industry
Health Care 2.66 2.77 2.95 2.93

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).

1 2022 Calculation
Financial leverage = Total assets ÷ Stockholders’ equity
= 5,391,700 ÷ 2,131,800 = 2.53

2 Click competitor name to see calculations.

Solvency ratio Description The company
Financial leverage ratio A solvency ratio calculated as total assets divided by total shareholders’ equity. DexCom Inc. financial leverage ratio decreased from 2020 to 2021 but then increased from 2021 to 2022 exceeding 2020 level.

Interest Coverage

DexCom Inc., interest coverage calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018
Selected Financial Data (US$ in thousands)
Net income (loss) 341,200 154,700 493,600 101,100 (127,100)
Add: Income tax expense 49,600 19,200 (268,600) 3,100 600
Add: Interest expense 18,600 100,300 84,700 60,300 22,700
Earnings before interest and tax (EBIT) 409,400 274,200 309,700 164,500 (103,800)
Solvency Ratio
Interest coverage1 22.01 2.73 3.66 2.73 -4.57
Benchmarks
Interest Coverage, Competitors2
Abbott Laboratories 15.89 16.41 10.10 7.09
Cigna Group 7.43 6.22 8.76 5.11
CVS Health Corp. 3.46 5.16 4.36 3.96
Elevance Health Inc. 10.13 10.93 8.96 9.02
Humana Inc. 9.89 11.49 17.52 15.34
Intuitive Surgical Inc.
Medtronic PLC 10.98 5.21 4.71 4.60
UnitedHealth Group Inc. 13.59 14.44 13.47 11.55
Interest Coverage, Sector
Health Care Equipment & Services 9.34 9.06 8.21 6.70
Interest Coverage, Industry
Health Care 12.97 12.85 7.67 8.84

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).

1 2022 Calculation
Interest coverage = EBIT ÷ Interest expense
= 409,400 ÷ 18,600 = 22.01

2 Click competitor name to see calculations.

Solvency ratio Description The company
Interest coverage ratio A solvency ratio calculated as EBIT divided by interest payments. DexCom Inc. interest coverage ratio deteriorated from 2020 to 2021 but then improved from 2021 to 2022 exceeding 2020 level.

Fixed Charge Coverage

DexCom Inc., fixed charge coverage calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018
Selected Financial Data (US$ in thousands)
Net income (loss) 341,200 154,700 493,600 101,100 (127,100)
Add: Income tax expense 49,600 19,200 (268,600) 3,100 600
Add: Interest expense 18,600 100,300 84,700 60,300 22,700
Earnings before interest and tax (EBIT) 409,400 274,200 309,700 164,500 (103,800)
Add: Operating lease cost 22,600 23,300 18,400 12,200 12,500
Earnings before fixed charges and tax 432,000 297,500 328,100 176,700 (91,300)
 
Interest expense 18,600 100,300 84,700 60,300 22,700
Operating lease cost 22,600 23,300 18,400 12,200 12,500
Fixed charges 41,200 123,600 103,100 72,500 35,200
Solvency Ratio
Fixed charge coverage1 10.49 2.41 3.18 2.44 -2.59
Benchmarks
Fixed Charge Coverage, Competitors2
Abbott Laboratories 10.10 10.21 6.68 5.14
Cigna Group 6.87 5.61 7.84 4.67
CVS Health Corp. 2.16 3.03 2.75 2.56
Elevance Health Inc. 8.82 8.48 6.10 7.34
Humana Inc. 7.10 8.05 12.02 9.76
Intuitive Surgical Inc. 63.52 93.66 58.48 79.65
Medtronic PLC 7.79 4.31 3.98 3.97
UnitedHealth Group Inc. 8.77 8.80 8.51 7.65
Fixed Charge Coverage, Sector
Health Care Equipment & Services 6.16 5.95 5.52 4.75
Fixed Charge Coverage, Industry
Health Care 9.19 9.09 5.67 6.58

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).

1 2022 Calculation
Fixed charge coverage = Earnings before fixed charges and tax ÷ Fixed charges
= 432,000 ÷ 41,200 = 10.49

2 Click competitor name to see calculations.

Solvency ratio Description The company
Fixed charge coverage ratio A solvency ratio calculated as earnings before fixed charges and tax divided by fixed charges. DexCom Inc. fixed charge coverage ratio deteriorated from 2020 to 2021 but then improved from 2021 to 2022 exceeding 2020 level.